ProMED
ProMED, a program of the International Society for Infectious Diseases, operates a 24/7 human-curated global infectious disease outbreak surveillance platform spanning human, animal, and plant health, serving WHO, CDC, governments, researchers, clinicians, and commercial users via tiered subscriptions, API access, and donations.
- Company typePrivate
- Founded1994
- HeadquartersBrookline, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What ProMED does
ProMED (Program for Monitoring Emerging Diseases) is a 24/7 global infectious disease outbreak surveillance service operated as a program of the International Society for Infectious Diseases (ISID), a Boston-based nonprofit professional organization. Founded in 1994 and maintaining a 31-year historical archive, ProMED curates and publishes outbreak intelligence across human, animal, and plant health using a One Health approach, staffed by ISID personnel plus a network of approximately 30 subject matter experts based in 24 countries who verify 5–20 critical health events daily and operate regional editions in multiple languages including English, Spanish, Russian, Portuguese, and Arabic.
The platform's core technology is human expert moderation supplemented by an AI Summary NLP layer that generates text digests of curated reports. Distribution is direct via a four-tier subscription model: a free Freemium tier with limited articles and truncated AI summaries, a Standard tier at $10/month (or $100/year), a Pro tier at $1,000/year for OECD small businesses, and a custom-priced Commercial/Government/Academic Research tier that includes bulk API access, webhooks, and multi-user organization accounts. Enterprise pricing is handled through a dedicated inquiry form, and the platform also solicits donations through Donorbox to sustain operations amid cited public health funding instability.
ProMED serves a globally distributed customer base spanning WHO, the US CDC, government health officials, physicians, veterinarians, academic researchers, journalists, AI-based disease surveillance platforms, and commercial organizations. Its go-to-market combines community-led acquisition (reputation, ISID ecosystem, global health conferences including ISID/ESCMID Global and ISID Congress) with sales-led enterprise motions for institutional and government contracts, and ecosystem partnerships with platforms such as Samdesk, GIDEON, EpiCore, and Transmissible that embed ProMED data into downstream operational and clinical workflows.
ProMED firmographics
Firmographics- Name
- ProMED
- Legal name
- International Society for Infectious Diseases
- Website
- https://promedmail.org
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ProMED, a program of the International Society for Infectious Diseases, operates a 24/7 human-curated global infectious disease outbreak surveillance platform spanning human, animal, and plant health, serving WHO, CDC, governments, researchers, clinicians, and commercial users via tiered subscriptions, API access, and donations.
- Ownership category
- akta.pro rank
ProMED industry classification
Industry- Product category
- Disease Surveillance and Outbreak Intelligence
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518), Computer Systems Design and Related Services (5415), Administration of Public Health Programs (923120)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Disease & Condition Surveillance Programs (HLAJANAB)
- akta.pro secondary industries
- Outbreak Investigation & Incident Management (EOC/ICS) (HLAJABAE), Population Health Surveillance & Epidemiologic Analytics (HLAJAJAB), Public Health & Immunization Data Exchange (ELR, case reporting, registry reporting) (HLACABAL), Disease Surveillance, Epidemiology & Outbreak Response (BPAIAJAA)
Keywords
Where ProMED is headquartered
LocationHeadquarters
- HQ city
- Brookline
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ProMED business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Subscription Revenue: ProMED generates revenue through tiered subscription plans: Freemium (free), Standard ($10/month or $100/year), Pro ($1,000/year), and Custom pricing for Commercial/Government/Academic institutions. The platform relies on donations from worldwide users to continue providing real-time disease outbreak information amid public health funding instability.
- Donations: ProMED accepts donations from worldwide users to maintain its global outbreak reporting services. The platform has called for support amid ongoing public health funding instability.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free tier for personal use only |
| Subscription | Monthly | Individual tier at $10/month or $100/year |
| Subscription | Annual | Small business tier at $1,000/year |
| Subscription | Multi-year contract | Custom pricing for organizations |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
ProMED product offering
Product offeringCore offering
ProMED (Program for Monitoring Emerging Diseases) operates a 24/7 global disease surveillance platform providing real-time, expert-curated outbreak reports across human, animal, and plant health. The platform is staffed by 30+ subject matter experts in 24 countries who verify and analyze 5-20 critical health events daily, supported by AI-generated summaries and a 31-year historical archive. It is offered via tiered subscriptions (Freemium, Standard, Pro, Commercial/Government/Academic Research) with API and webhook access for enterprise users, and serves WHO, CDC, universities, governments, physicians, veterinarians, and journalists worldwide.
Product overview
ProMED (Program for Monitoring Emerging Diseases) is a unified disease surveillance platform operated by the International Society for Infectious Diseases (ISID), launched in 1994. The core product is the ProMED Disease Surveillance Platform providing 24/7 global outbreak reporting across human, animal, and plant health using a One Health approach. The platform is supplemented by ProMED's Weekly Pulse for weekly summaries. ProMED offers a tiered subscription model: Freemium (free, limited), Standard ($10/mo), Pro ($1,000/yr), and Commercial/Government/Academic Research (custom pricing with API/webhook access). AI Summary functionality generates text summaries of reports across all paid tiers. The platform maintains a 31-year historical archive and is staffed by 30 subject matter experts across 24 countries.
Differentiator
Problem solved
Functional benefit
Products and services
- ProMED Disease Surveillance Platform The flagship 24/7 global infectious disease outbreak reporting platform covering human, animal, and plant health using a One Health approach. Provides expert-curated outbreak reports verified by 30+ subject matter experts in 24 countries, supported by a 31-year historical archive, customizable search, AI-generated summaries, and tiered subscription access. Used by the WHO, US CDC, universities, governments, physicians, veterinarians, and journalists worldwide.
- ProMED's Weekly Pulse A weekly snapshot of global health events from the past seven days, providing curated summaries of recent disease outbreak activity. Delivered via the ProMED website to complement the real-time core reporting stream.
- ProMED Commercial / Government / Academic Research Subscription
Quantifiable outcome
- First to report numerous major disease outbreaks including SARS, Chikungunya, early Ebola spread, Zika, MERS, and COVID-19
- +2 more outcomes
Companies that use ProMED
Customer profileNamed customers8 records
Segments6 records
Ideal customer profiles4 records
ProMED technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
ProMED partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- SamdeskcoreSamdesk is a Preferred Partner of ProMED, integrating real-time ProMED outbreak alerts into their operational intelligence platform. Samdesk processes text and sensory data to support safer, more efficient organizations and societies, providing real-time alerts to operational disruptions. This partnership extends ProMED's reach into corporate and government operational security markets.
- GIDEON (GIDEON Informatics)minorGIDEON is listed as a user partner on ProMED's Preferred Partners page. GIDEON provides global infectious disease database tools used by healthcare professionals worldwide.
- EpiCoreminorEpiCore is listed as a user partner on ProMED's Preferred Partners page. EpiCore is a global network of health professionals sharing surveillance information.
- Transmissible (TGH)minorTransmissible (TGH) is listed as a user partner on ProMED's Preferred Partners page.
- International Society for Infectious Diseases (ISID)coreProMED is a program of the International Society for Infectious Diseases (ISID). ISID provides institutional support, staffing, and organizational infrastructure. The society operates from 867 Boylston Street, Boston, MA 02116, USA. ISID also hosts major conferences including ISID/ESCMID Global and ISID Congress where ProMED maintains a presence.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
ProMED competitors and assessment
Company assessmentEmerging players
- Flu Near You / Outbreaks Near You (Boston Children's Hospital): Outbreaks Near You aggregates crowdsourced and traditional surveillance signals for public-facing outbreak tracking. It is a narrower, public-facing adjacent surveillance platform rather than a full ProMED competitor.
- EpiCore: EpiCore is a verified network of human health professionals that crowdsources and validates surveillance signals using a similar expert-moderation approach to ProMED. It is a Preferred Partner of ProMED but represents an adjacent, narrower community-led threat.
- AstraZeneca Foundation Disease Surveillance / Ending Pandemics: Ending Pandemics (formerly InSTEDD iLab) supports volunteer-based disease surveillance networks (e.g., in Thailand and Sri Lanka) using community reporting infrastructure analogous to ProMED's expert network. Operates in a smaller scope but uses a comparable human-network approach.
Direct peers
- HealthMap: HealthMap (Boston Children's Hospital / Harvard Medical School) is one of the most well-known real-time infectious disease surveillance aggregators. Like ProMED, it ingests global signals and surfaces outbreak alerts to public health users, making it a closely comparable direct peer in disease intelligence.
- BlueDot: BlueDot is a Toronto-based AI-driven global infectious disease intelligence platform that monitors, contextualizes, and forecasts outbreaks for government and enterprise clients. It is the canonical 'AI-native' counterpart to ProMED's expert-curated model.
- GIDEON Informatics: GIDEON is a long-standing infectious disease reference and surveillance database used by clinicians and public health professionals. It is already listed as a ProMED user partner, shares the same target buyer base (physicians, epidemiologists), and competes for paid subscriptions in the same intelligence category.
- Metabiota: Metabiota built an epidemic risk platform using global infectious disease surveillance data for insurers, governments, and humanitarian organizations. It competes for the same institutional outbreak-intelligence budgets that ProMED targets with its Commercial tier.
Broad incumbents
- CIDRAP (Center for Infectious Disease Research and Policy): CIDRAP at the University of Minnesota publishes curated, expert-vetted outbreak and policy news to a global health audience. It serves overlapping public-health and research subscribers and is a broad incumbent rather than a direct subscription competitor.
Others
- World Health Organization DON (Disease Outbreak News): WHO's Disease Outbreak News is the official agency output that ProMED often pre-empts. They are both authoritative outbreak-information sources, but WHO is a public-sector publisher while ProMED is a curated subscription/feed product.
- HealthLine / Outbreak News Today: Outbreak News Today publishes continuously curated global outbreak summaries for journalists and health-conscious readers. It overlaps significantly with ProMED's media/journalist segment but redistributes rather than originates primary reporting.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
ProMED social profiles
Digital presenceProMED financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProMED leadership team
Management profileNumber of profiles
Profiles8 records
ProMED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProMED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProMED
What does ProMED do?
ProMED (Program for Monitoring Emerging Diseases) operates a 24/7 global disease surveillance platform providing real-time, expert-curated outbreak reports across human, animal, and plant health. The platform is staffed by 30+ subject matter experts in 24 countries who verify and analyze 5-20 critical health events daily, supported by AI-generated summaries and a 31-year historical archive. It is offered via tiered subscriptions (Freemium, Standard, Pro, Commercial/Government/Academic Research) with API and webhook access for enterprise users, and serves WHO, CDC, universities, governments, physicians, veterinarians, and journalists worldwide.
Is ProMED a public or private company?
ProMED is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was ProMED founded?
ProMED was founded in 1994. It employs 11 to 50 people.
Where is ProMED based?
ProMED is headquartered in Brookline, United States, in the North America region.
How does ProMED make money?
Two revenue lines are on record. Subscription Revenue is the primary driver. The others are donations.
Who are ProMED's main competitors?
Emerging players on record are Flu Near You / Outbreaks Near You (Boston Children's Hospital), EpiCore and AstraZeneca Foundation Disease Surveillance / Ending Pandemics. Direct peers are HealthMap, BlueDot, GIDEON Informatics and Metabiota. CIDRAP (Center for Infectious Disease Research and Policy) is listed as a broad incumbent. Others are World Health Organization DON (Disease Outbreak News) and HealthLine / Outbreak News Today.
Does ProMED have an API?
Yes. ProMED offers API access as part of its Commercial/Government/Academic Research subscription tier. Bulk API access is available for enterprise users with pricing upon request. The API enables data access via email, website, and programmatic methods. Webhook functionality is available for Commercial/Government/Academic Research tier users upon inquiry. Individual Standard and Pro tiers do not include API access.
What industry is ProMED in?
ProMED's product category is Disease Surveillance and Outbreak Intelligence. Its primary akta.pro industry code is HLAJANAB, Disease & Condition Surveillance Programs, with a secondary code of HLAJABAE, Outbreak Investigation & Incident Management (EOC/ICS). Its NAICS code is 518 and its SIC code is 7372.